Discover the detailed record of transactions filed by Wedell-Wedellsborg Johan, Director. Director active across 1 companies, notably Y-mAbs Therapeutics, Inc.. In total, 10 disclosures have been recorded. Total volume traded: €9.8m. The latest transaction was disclosed on 10 June 2021 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Johan Wedell-Wedellsborg is a Director at Y-mAbs Therapeutics, Inc. He plays a key role in overseeing the company's activities and strategic direction. His expertise in the biotechnology field allows him to contribute to the innovation and growth of the company.